Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ:072020)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,290.00
0.00 (0.00%)
At close: Sep 3, 2026

KOSDAQ:072020 Revenue

Choong Ang Vaccine Laboratory had revenue of 10.23B KRW in the quarter ending March 31, 2023, a decrease of -1.05%. This brings the company's revenue in the last twelve months to 39.19B, down -4.18% year-over-year. In the year 2022, Choong Ang Vaccine Laboratory had annual revenue of 39.30B, down -3.95%.

Revenue (ttm)
39.19B
Revenue Growth
-4.18%
P/S Ratio
2.19
Revenue / Employee
234.67M
Employees
167
Market Cap
86.00B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202239.30B-1.61B-3.95%
Dec 31, 202140.91B4.60B12.66%
Dec 31, 202036.32B17.05B88.53%
Dec 31, 201219.26B3.67B23.57%
Dec 31, 201115.59B-507.67M-3.15%
Dec 31, 2010 Pro Pro Pro
Dec 31, 2009 Pro Pro Pro
Dec 31, 2008 Pro Pro Pro
Dec 31, 2007 Pro Pro Pro
Dec 31, 2006 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
CTCBIO131.54B
Cell Biotech60.40B
Naturalendo Tech22.79B
BIO-FD&C19.53B
CORESTEMCHEMON18.29B
PanGen Biotech14.18B
ADBiotech12.57B
EyeGene4.48B
Revenue Rankings